Links Progenetics & GTC ProGenetics received $0.5 million and will get an additional amount of approximately $0.5 million in the second quarter of 2008. GTC will also receive a small equity interest in the company... ProGenetics also obtained a nonexclusive license to GTC’s patent in the U.S. for the transgenic expression of therapeutic proteins in milk. This will enable the company to develop these products outside North America, Europe, and Japan.
GTC previously obtained from ProGenetics an exclusive license to a number of recombinant plasma proteins including human coagulation factor IX, for North America, Europe, and Japan. ProGenetics received $500,000 upon signing of that agreement. LFB will fund the final $500,000 license fee payment due to ProGenetics in the second quarter of 2008. http://www.genengnews.com/news/bnitem.as...
During Q4 2008, two monoclonal antibodies developed by LFB's R&D division (an anti-D monoclonal and a batch of anti-CD 20) both achieved a significant development milestone - first-in-man administration.